Daiichi Sankyo Europe competitive analysis

Explore patent oppositions filed by Daiichi Sankyo Europe against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Cell Growth InhibitionTHE VICTOR CHANG CARDIAC RESEARCH INSTITUTEJun 1, 2015

Explore Daiichi Sankyo Europe's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 24, 2018Activated Her3 As A Marker For Predicting Therapeutic Efficacy1

Latest PTAB cases involving Daiichi Sankyo Europe

Discover the latest PTAB cases involving Daiichi Sankyo Europe, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Daiichi Sankyo Europe with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DAIICHI SANKYO EUROPE11 - -
F HOFFMANN LA ROCHE34257 - -
THE VICTOR CHANG CARDIAC RESEARCH INSTITUTE - 1 - -
ZENSUN SHANGHAI SCIENCE AND TECHNOLOGY - 2 - -